Lyra Health Revenue, Valuation, Funding & Investors

Lyra Health is valued at $5.8B as of January 2022.

Last Lyra Health valuation

$5.8B

Series F · Jan 2022

Last Lyra Health funding round

$235M

Series F · Jan 2022

Lyra Health revenue

$100M

Series E · Jan 2021

Key investors in Lyra Health

  • Venrock
  • Greylock
  • Coatue
  • IVP
  • Casdin Capital
  • Addition

Lyra Health Overview

About Lyra Health

Lyra Health is a Burlingame, California-headquartered provider of mental health benefits for employers, serving over 15 million covered lives at companies like Uber, Netflix, and eBay. Its platform uses AI-driven matching to connect employees with 5,000 licensed therapists and coaches, achieving 3x higher utilization rates than industry averages. Lyra Health offers services including therapy, coaching, psychiatry, and digital tools for conditions like anxiety and depression. Founded in 2015, the company raised $200 million in Series D funding in 2021 and expanded into Medicare Advantage plans.


Founded

2015

HQ

United StatesCalifornia City, CA

Status

Privately held

Customer focus

B2B

Revenue model

Services

Revenue

$100M (Jan 2021)

Valuation

$5.8B (Jan 2022)

Lyra Health Valuation

Lyra Health is currently valued at $5.8B, based on its Series F in January 2022.

The $235M round was led by Dragoneer, with participation from Salesforce Ventures, Emerson Collective and Coatue.

Lyra Health's valuation has grown 5.3x from $1.1B at its Series D in August 2020 to $5.8B in January 2022, across 4 priced rounds.

Lyra Health valuation by funding round

Revenue multiple
Lyra Health valuation by funding round
DateStageValuationRevenue Multiple
Jan 2022Series F$5.8B-
May 2021Series F$4.6B-
Jan 2021Series E$2.3B23.0x
Aug 2020Series D$1.1B11.0x

Lyra Health Revenue

Lyra Health's latest recorded revenue is $100M, as of its Series E in January 2021. At a $2.3B valuation, that implies a 23.0x revenue multiple.

Revenue moved from $100M in August 2020 to $100M in January 2021, while the revenue multiple moved from 11.0x to 23.0x.

Lyra Health revenue by funding round

Lyra Health revenue and valuation multiple by funding round
DateRevenue *ValuationRevenue MultipleStage
Jan 2021$100M$2.3B23.0xSeries E
Aug 2020$100M$1.1B11.0xSeries D

* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.

Lyra Health Funding History

Lyra Health has raised a total of $910M across 8 funding rounds.

Lyra Health's first fundraising round was a $3M seed round in June 2015. The most recent completed round was a $235M Series F in January 2022.

Lyra Health funding rounds

Lyra Health funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Jan 2022Series FDragoneer (lead); Salesforce Ventures; Emerson Collective; Coatue$235M$5.8BLyra Health, a Burlingame, California-based provider of innovative workforce mental health solutions for employers, completed a $235 million Series G funding round on January 19, 2022, led by Dragoneer Investment Group with participation from new investor Salesforce Ventures and existing investor Coatue. The round propelled the company's post-money valuation to $5.58 billion, up from $4.6 billion following its prior $200 million Series E in June 2021. The funding aims to accelerate international expansion and delivery of comprehensive, evidence-based mental health care benefits. Alongside the financing, Lyra announced the acquisition of ICAS World, an employee assistance program provider operating in over 155 countries, enabling culturally responsive services including preventive care, mental health coaching, therapy, and medication on a single platform for more than 10 million global members—expanding from prior coverage of 2.2 million members. The company serves leading employers such as Amgen, Uber, and Morgan Stanley, offering in-person and virtual behavioral health benefits to address growing demand for accessible mental health services. Lyra has raised approximately $915 million to $926 million across 11 funding rounds to date, with investors including Institutional Venture Partners, Sands Capital, Addition, and others. Dragoneer, a growth-oriented firm managing over $25 billion, highlighted CEO David Ebersman's leadership in redefining mental health access through employer solutions. The company leverages AI-powered matching to connect individuals with providers for therapy, coaching, and medication management, serving millions globally.
May 2021Series FCoatue (lead); IVP; Sands Capital Ventures$200M$4.6BLyra Health is a Burlingame, California-based provider of comprehensive mental health care benefits for employers, connecting employees and families to high-quality therapists, coaches, and doctors via in-person, video therapy, and digital tools using evidence-based treatments like Cognitive Behavioral Therapy. The company matches users with providers through an algorithmic process based on availability and skillset, serving clients like eBay, Genentech, Uber, and VCA Animal Hospitals, with over 2.2 million members globally at the time of the round. In June 2021, Lyra Health completed a $200 million Series F funding round led by Coatue, joined by new investor Sands Capital Ventures and existing investors including IVP, boosting its post-money valuation to $4.6 billion. This followed a $187 million Series E in January 2021 and a $110 million Series D in August 2020, bringing total funding to approximately $675-680 million. The round was first reported in May 2021 by The Information ahead of the official announcement. Lyra plans to use the funds to expand evidence-based mental health benefits internationally, enhancing solutions for multinational companies through a partnership with global EAP provider ICAS, covering 180 countries, and launching a new mobile app in 2022 with therapy, coaching, medication access, and preventive tools for stress, sleep, parenting, and meditation. A peer-reviewed study showed Lyra’s Blended Care Therapy improved or recovered 83% of participants from anxiety or depression, far exceeding the 24% in traditional plans. The mental health space saw surging demand during the COVID-19 pandemic, with digital behavioral health investments nearly tripling to $1.8 billion across 55 deals in 2020 per Rock Health. Lyra, founded in 2015, reached unicorn status in 2020 and competes with players like Ginger (text coaching/teletherapy, Cigna partnership) and Headway (insurer-covered therapist network), focusing on employer benefits amid research showing 83% of U.S. employees facing mental health issues and 40% feeling unsupported by employers.
Jan 2021Series EAddition (lead); Baillie Gifford; Fidelity; Durable Capital Partners$187M$2.3BLyra Health is a Burlingame, California-based company providing personalized mental health care benefits to employees of major employers like Amgen, Uber, and Morgan Stanley through in-person and virtual services addressing conditions including alcohol use disorder and suicidality. On January 28, 2021, Lyra Health raised $187 million in its Series E funding round led by Addition, with participation from Baillie Gifford (via Scottish Mortgage Investment Trust), Durable Capital Partners, Fidelity Investments, Institutional Venture Partners, Sands Capital, and other undisclosed investors. Subsequent rounds included a June 2021 Series F raising $200 million at $4.6 billion valuation led by Coatue and others, followed by a January 2022 Series G raising $235 million led by Dragoneer at $5.58-$5.585 billion valuation, coinciding with the acquisition of ICAS World to expand to over 10 million global members across 155 countries.
Aug 2020Series DAddition (lead)$110M$1.1BLyra Health is a Burlingame, California-based provider of mental health care benefits for employers, offering AI-powered services including virtual visits with providers, digital exercises, and a network of licensed therapists. The company announced its $110 million Series D funding round on August 25, 2020, led by Addition with participation from Adams Street Partners and existing investors such as Howard Schultz, Casdin Capital, Glynn Capital, Greylock Partners, IVP, Meritech Capital Partners, Providence Ventures, and Tenaya Capital. This round elevated Lyra's post-money valuation to $1.1 billion, granting it unicorn status, and brought total funding raised to approximately $288-292 million. The funding came amid surging demand for mental health services during the COVID-19 pandemic, with Lyra adding over 800,000 new members in 2020 to reach a total of more than 1.5 million members across its employer clients. In August 2020, the company projected it would hit more than $100 million in revenue by the end of the year. Lyra planned to use the capital to expand its client and provider networks, invest in tech-enabled treatments, and scale teletherapy services. This Series D followed a $75 million Series C in March 2020 and preceded further raises, including a $187 million Series E in late 2020 or early 2021 that valued the company at $2.3 billion. Lyra's growth positioned it in the competitive mental health benefits space, where startups collectively raised record equity funding in 2020, as employers increasingly offered comprehensive behavioral health solutions.
Mar 2020Series CIVP (lead); Tenaya Capital; Casdin Capital; Allumia Ventures; Venrock; Greylock; Glynn Capital Management; Crown Venture Fund; Meritech Capital Partners$75M-Lyra Health is a Burlingame, California-based provider of mental health benefits for employers, offering personalized recommendations for therapy, coaching, and medications, with fast access to top evidence-based providers and technology to support care between sessions. On March 11, 2020, the company closed a $75 million Series C financing round led by IVP, joined by new investor Meritech Capital Partners and existing investors Casdin Capital, Crown Venture Fund, Glynn Capital Management, Greylock, Providence Ventures, Tenaya Capital, and Venrock. The funding was intended to expand its platform technology and network of evidence-based mental health providers amid surging mental illness prevalence. Around the time of the Series D, Forbes reported Lyra was on track for approximately $100 million in revenue by year-end 2020, reflecting rapid growth driven by the COVID-19 pandemic's impact on mental health needs. The company added over 800,000 new members in 2020, reaching more than 1.5 million total eligible members, and was set to deliver its one-millionth session of care. Lyra's traction included partnerships with major employers like Starbucks and Zoom, providing no-cost mental health services such as therapy and coaching. The company focused on innovations like Lyra Blended Care, combining video therapy with digital CBT-based exercises. Subsequent rounds included a planned Series E at $2.25 billion valuation in late 2020 and further growth to $4.6 billion in 2021, with total funding exceeding $900 million by later stages.
May 2018Undisclosed stageTenaya Capital; Casdin Capital; Allumia Ventures; Venrock; Greylock; Glynn Capital Management; Crown Venture Fund$65M--
Oct 2015Series AGreylock (lead); Venrock (lead); Breyer Capital; Castlight Health; Providence Health & Services; Origin Capital Management$35M-Lyra Health raised $35 million in a Series A funding round on October 14, 2015, led by Greylock Partners and Venrock, with participation from Castlight Health, Providence Health & Services, Breyer Capital, and Origin Capital Management. The company, founded by former Facebook and Genentech CFO David Ebersman, launched in June 2015 to address mental health care challenges by working with employers, health plans, and providers to improve behavioral health outcomes through technology and human coordination. Lyra identifies, engages, and matches patients with appropriate providers and treatments for mental health conditions and substance abuse, while assessing outcomes to optimize care. The funding was intended to make Lyra's technology available to select enterprise and health plan customers starting in Q1 2016, with full commercial availability planned for 2017, and to expand its technology and clinical teams. Greylock Partner James Slavet highlighted the company's potential to impact quality of life and employer costs in a broken mental health system. The US spends around $100 billion annually on direct treatment of mental health and substance abuse, plus $400 billion in indirect costs, with $200 billion lost to disability, absenteeism, and presenteeism. Subsequent rounds included a $75M Series C in March 2020 led by IVP and a $110M Series D in 2020, reflecting growth in membership to over 1.5 million and partnerships with companies like Morgan Stanley and Zoom, but these are unrelated to the 2015 round.
Jun 2015SeedVenrock (lead); Castlight Health$3M-Lyra Health, a mental health startup co-founded by former Facebook CFO David Ebersman, launched in June 2015. The company focuses on transforming mental health care by matching employees with providers and tracking outcomes. No details available on a specific funding round in June 2015 involving Castlight Health and Venrock as lead. Subsequent rounds include a $35 million Series A in October 2015 led by Greylock Partners with participation from Venrock and Castlight Health.

Who has invested in Lyra Health?

22 investors have backed Lyra Health across its funding rounds, including Venrock, Greylock, Coatue, IVP, Casdin Capital and Addition.

Lead investors include Dragoneer, Coatue, Addition, IVP, Greylock and 1 other investor.


Lyra Health Investors

Investors in Lyra Health by funding rounds participated
InvestorHQRoundsRoleFirst check
VenrockUnited StatesSan Francisco, CA4LeadJun 2015
GreylockUnited StatesSan Francisco, CA3LeadOct 2015
Tenaya CapitalUnited StatesSan Francisco, CA2ParticipantMay 2018
IVPUnited StatesSan Francisco, CA2LeadMar 2020
Castlight HealthUnited StatesSan Francisco, CA2ParticipantJun 2015
Casdin CapitalUnited StatesNew York City, NY2ParticipantMay 2018
Allumia VenturesUnited StatesSeattle, WA2ParticipantMay 2018
AdditionUnited StatesUnited States2LeadAug 2020
CoatueUnited StatesNew York City, NY2LeadMay 2021
Glynn Capital ManagementUnited StatesSan Francisco, CA2ParticipantMay 2018
Crown Venture FundUnited StatesWest Palm Beach, FL2ParticipantMay 2018
Baillie GiffordUnited KingdomEdinburgh1ParticipantJan 2021
Breyer CapitalUnited StatesSan Francisco, CA1ParticipantOct 2015

This data is available for Pro users. Sign up to see all 22 Lyra Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Lyra Health

Lyra Health has acquired 2 companies to date.

Last acquisition by Lyra Health was on July 16th 2025. Lyra Health acquired Bend Health for undisclosed valuation.


Latest Acquisitions by Lyra Health

Bend Health
ICAS World
Description
Bend Health is a telehealth provider specializing in pediatric mental health for children and teens up to age 21. Services include virtual therapy, psychiatry evaluations, coaching, and family support via a platform integrating EHR and AI-driven care plans. Founded by healthcare veterans from Optum and Teladoc, the San Francisco-based company operates in 70 US states, partnering with pediatricians for referrals and achieving 40 percent faster access to specialists.
ICAS World is a Dublin-headquartered provider of employee assistance programs serving over 20 million people across 100 countries. It delivers 24/7 counseling via phone, chat, and app for mental health, legal advice, and financial wellness, with critical incident response for workplaces. Operating since 1994, ICAS partners with multinational corporations like Unilever and supports EAPs tailored to sectors including healthcare and manufacturing through localized language services.
HQ CountryUnited StatesUnited Kingdom
HQ City
Madison, WI
London
Deal Date16 Jul 202519 Jan 2022
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Lyra Health acquisitions and their M&A valuation multiples.

Start Free Trial

Lyra Health Competitors

Lyra Health competitors include listed companies like Hims and Doximity, and private ones like Cerebral, Spring Health, Grow Therapy and Headway.

Public and private companies comparable to Lyra Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
HimsUnited StatesUnited StatesPublicly listed$2.3B$178M$6.5B2.4x
CerebralUnited StatesSan Francisco, CAPrivate--$4.8B-
DoximityUnited StatesUnited StatesPublicly listed$645M$229M$4.7B6.2x
Spring HealthUnited StatesNew York City, NYPrivate$125M-$3.3B26.4x
Grow TherapyUnited StatesNew York City, NYPrivate$1B-$3B-
HeadwayUnited StatesNew York City, NYPrivate--$2.3B-

Lyra Health Public Comps

Lyra Health is still privately-owned, but its public comps include Hims, Doximity, ACADIA Pharmaceuticals, Compass Pathways, Teladoc, Talkspace, Evolent Health, Outset Medical, Everkind Wellness and Humana Inc..

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Hims$2.3B$178M3.1x2.4x40.4x23.9x
Doximity$645M$229M6.3x6.2x17.7x11.9x
ACADIA Pharmaceuticals$1.1B$119M3.6x3.2x32.3x33.6x
Compass Pathways-($293M)--(5.8x)(8.4x)
Teladoc$2.5B$124M0.6x0.6x11.3x5.0x
Talkspace$229M$6M3.4x3.4x129.3x49.4x
Evolent Health$1.9B($365M)0.7x0.5x(3.5x)9.4x
Outset Medical$119M($70M)0.1x0.1x(0.2x)(0.3x)

This data is available for Pro users. Sign up to see all Lyra Health competitors and their valuation data.

Start Free Trial

Common questions about Lyra Health

When was Lyra Health founded?Lyra Health was founded in 2015.
Where is Lyra Health headquartered?Lyra Health is headquartered in California City, CA, United States.
Is Lyra Health publicly listed?No, Lyra Health is a private, VC-backed company.
What is Lyra Health's valuation?Lyra Health was last valued at $5.8B in its Series F in January 2022.
How much funding has Lyra Health raised?Lyra Health has raised $910M across 8 funding rounds.
What was Lyra Health's last funding round?Lyra Health's last funding round was a $235M Series F in January 2022, led by Dragoneer.
Who are Lyra Health's investors?Lyra Health's investors include Venrock, Greylock, Tenaya Capital, IVP, Castlight Health, Casdin Capital, Allumia Ventures, Addition, Coatue, Glynn Capital Management and 12 others.
What is Lyra Health's revenue?Lyra Health's latest recorded revenue is $100M (January 2021).
What is Lyra Health's revenue multiple?Lyra Health's latest valuation implies a 23.0x revenue multiple ($2.3B valuation on $100M of revenue).
Which companies are comparable to Lyra Health?Companies comparable to Lyra Health include Hims, Cerebral, Doximity, Spring Health, Grow Therapy and Headway.
How many companies has Lyra Health acquired?Lyra Health has acquired 2 companies, including Bend Health and ICAS World.

See companies similar to Lyra Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial